Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.44 - $1.22 $44 - $122
100 Added 0.22%
45,301 $31,000
Q2 2023

Aug 14, 2023

SELL
$1.5 - $3.04 $255,571 - $517,958
-170,381 Reduced 79.03%
45,201 $72,000
Q1 2023

May 15, 2023

SELL
$2.8 - $5.46 $266,644 - $519,955
-95,230 Reduced 30.64%
215,582 $625,000
Q4 2022

Feb 14, 2023

BUY
$2.85 - $5.18 $437,968 - $796,026
153,673 Added 97.79%
310,812 $1.02 Million
Q3 2022

Nov 14, 2022

BUY
$2.85 - $8.73 $87,352 - $267,574
30,650 Added 24.23%
157,139 $594,000
Q2 2022

Aug 15, 2022

SELL
$4.69 - $9.84 $112,147 - $235,294
-23,912 Reduced 15.9%
126,489 $985,000
Q1 2021

May 17, 2021

BUY
$14.0 - $20.72 $632,814 - $936,564
45,201 Added 42.97%
150,401 $2.16 Million
Q4 2020

Feb 03, 2021

SELL
$12.67 - $26.23 $406,745 - $842,061
-32,103 Reduced 23.38%
105,200 $2.07 Million
Q3 2020

Nov 16, 2020

BUY
$11.92 - $15.87 $133,504 - $177,744
11,200 Added 8.88%
137,303 $1.78 Million
Q2 2020

Aug 12, 2020

BUY
$7.53 - $14.93 $264,325 - $524,087
35,103 Added 38.57%
126,103 $1.84 Million
Q1 2020

May 06, 2020

BUY
$5.69 - $17.78 $138,836 - $433,832
24,400 Added 36.64%
91,000 $774,000
Q3 2019

Nov 12, 2019

BUY
$12.03 - $19.94 $68,571 - $113,658
5,700 Added 9.36%
66,600 $940,000
Q2 2019

Aug 14, 2019

BUY
$19.05 - $41.04 $60,960 - $131,328
3,200 Added 5.55%
60,900 $1.23 Million
Q1 2019

May 13, 2019

BUY
$28.4 - $41.74 $408,960 - $601,056
14,400 Added 33.26%
57,700 $2.29 Million
Q4 2018

Feb 11, 2019

BUY
$30.9 - $42.97 $58,710 - $81,643
1,900 Added 4.59%
43,300 $1.5 Million
Q2 2018

Aug 03, 2018

BUY
$35.15 - $51.45 $509,675 - $746,025
14,500 Added 53.9%
41,400 $1.52 Million
Q1 2018

May 07, 2018

BUY
$18.0 - $48.35 $160,200 - $430,315
8,900 Added 49.44%
26,900 $1.05 Million
Q3 2017

Nov 01, 2017

BUY
$13.25 - $17.05 $238,500 - $306,900
18,000
18,000 $298,000

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $1.26B
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.